Moderna Expects Earliest Potential Approvals For mRNA-1010 To Begin In Late 2026 Or Early 2027
Moderna +4.26% Post
Moderna MRNA | 52.84 52.83 | +4.26% -0.02% Post |
Moderna Expects Earliest Potential Approvals For mRNA-1010 To Begin In Late 2026 Or Early 2027
